[1]
|
Shishehbor, M.H., Jaff, M.R. (2016) Percutaneous Therapies for Peripheral Artery Disease. Circulation, 134, 2008-2027. https://doi.org/10.1161/CIRCULATIONAHA.116.022546
|
[2]
|
王凤梅, 张鹏, 宋北, 等. 高血压中医证型与出凝血指标的相关性分析[J]. 国际检验医学杂志, 2019, 40(1):12-15.
|
[3]
|
杨洁, 乔娟娟, 陆耕宇, 等. 土茯苓的本草考证[J]. 现代中药研究与实践, 2021, 35(4): 98-102.
|
[4]
|
屠道和著. 本草汇纂[M]. 苗彦霞, 赵宏岩, 校注. 北京: 中国中医药出版社, 2016: 118.
|
[5]
|
Song, P., Rudan, D., Zhu, Y., et al. (2019) Global, Regional, and National Prevalence and Risk Factors for Peripheral Artery Disease in 2015: An Updated Systematic Review and Analysis. The Lancet Global Health, 7, E1020-E1030. https://doi.org/10.1016/S2214-109X(19)30255-4
|
[6]
|
Virani, S.S., Alonso, A., Aparicio, H.J., et al. (2021) Heart Disease and Stroke Statistics-2021 Update: A Report from the American Heart Association. Circulation, 143, e254-e743. https://doi.org/10.1161/CIR.0000000000000950
|
[7]
|
Libby, P. (2021) the Changing Landscape of Atherosclerosis. Nature, 592, 524-533. https://doi.org/10.1038/s41586-021-03392-8
|
[8]
|
Cheng, Y., Liu, Y., Tan, J., et al. (2020) Integrated Serum Metabolomics and Network Pharmacology Approach to Reveal the Potential Mechanisms of Withanolides from the Leaves of Datura metel L. on Psoriasis. Journal of Pharmaceutical and Biomedical Analysis, 186, Article ID: 113277. https://doi.org/10.1016/j.jpba.2020.113277
|
[9]
|
世界中医药学会联合会. 网络药理学评价方法指南[J]. 世界中医药, 2021, 16(4): 527-532.
|
[10]
|
李玉琪, 袁婷婷, 茅风燕, 等. 落新妇苷的药理活性及植物来源研究进展[J]. 中国药房, 2017, 28(19): 2718-2723.
|
[11]
|
Wang, G., Wang, Y., Yao, L., et al. (2022) Pharmacological Activity of Quercetin: An Updated Review. Evidence-Based Complementary and Alternative Medicine, 2022, Article ID: 3997190. https://doi.org/10.1155/2022/3997190
|
[12]
|
唐玉林, 张博, 任曼, 等. UPLC-MS/MS代谢组学评价归芪益母口服液对产后奶牛瘤胃的调节作用[J]. 中国农业科学, 2023, 56(2): 368-378.
|
[13]
|
Li, S., Cao, H., Shen, D., et al. (2020) Effect of Quercetin on Atherosclerosis Based on Expressions of ABCA1, LXR-α and PCSK9 in ApoE-/-Mice. Chinese Journal of Integrative Medicine, 26, 114-121. https://doi.org/10.1007/s11655-019-2942-9
|
[14]
|
Döring, Y., Noels, H., Van Der Vorst, E.P.C., et al. (2017) Vascular CXCR4 Limits Atherosclerosis by Maintaining Arterial Integrity: Evidence from Mouse and Human Studies. Circulation, 136, 388-403. https://doi.org/10.1161/CIRCULATIONAHA.117.027646
|
[15]
|
刘玄林, 熊伟. 槲皮素调节SDF-1/CXCR4轴对下肢动脉硬化闭塞症大鼠的治疗作用[J]. 中国现代应用药学, 2023, 40(4): 455-460.
|
[16]
|
Sun, S., Yan, Z., Shui, X., et al. (2020) Astilbin Prevents Osteoarthritis Development through the TLR4/MD-2 Pathway. Journal of Cellular and Molecular Medicine, 24, 13104-13114. https://doi.org/10.1111/jcmm.15915
|
[17]
|
李玉琪, 周承明, 王晓雯, 等. 赤土茯苓甙对异丙肾上腺素诱发的小鼠缺血心肌的保护作用[J]. 中草药, 1996(7): 418-420.
|
[18]
|
Motoyashiki, T., Miyake, M., Morita, T., et al. (1998) Enhancement of the Vanadate-Stimulated Release of Lipoprotein Lipase Activity by Astilbin from the Leaves of Engelhardtia Chrysolepis. Biological and Pharmaceutical Bulletin, 21, 517-519. https://doi.org/10.1248/bpb.21.517
|
[19]
|
Babaev, V.R., Ding, L., Zhang, Y., et al. (2019) Loss of 2 Akt (Protein Kinase B) Isoforms in Hematopoietic Cells Diminished Monocyte and Macrophage Survival and Reduces Atherosclerosis in Ldl Receptor-Null Mice. Arteriosclerosis, Thrombosis, and Vascular Biology, 39, 156-169. https://doi.org/10.1161/ATVBAHA.118.312206
|
[20]
|
刘公理, 吴赛珠, 阮云军, 等. 多种生化标志物与颈动脉粥样硬化斑块稳定性的关系[J]. 山东医药, 2012, 52(5): 7-9.
|
[21]
|
张安邦, 高杰, 李令根, 等. 相关炎症因子与动脉粥样硬化的关系[J]. 中国中西医结合外科杂志, 2014, 20(5): 563-566.
|
[22]
|
宋珂, 侯彦宏, 苏都娜, 等. 四妙勇安汤对ApoE-/-动脉粥样硬化小鼠IL-6和MCP-1的影响[J]. 中国现代中药, 2019, 21(4): 441-447.
|
[23]
|
Braile, M., Marcella, S., Cristinziano, L., et al. (2020) VEGF-A in Cardiomyocytes and Heart Diseases. International Journal of Molecular Sciences, 21, Article 5294. https://doi.org/10.3390/ijms21155294
|
[24]
|
陈豫贤, 于淑君, 姜正明, 等. LncRNA Gm4419靶向MiR-204-5p调控LPS诱导的心肌细胞损伤机制[J]. 中国老年学杂志, 2022, 42(6): 1459-1463.
|
[25]
|
刘枫, 张韩, 李彦明, 等. LncRNA SLC8A1-AS1在脓毒症大鼠心肌组织中的表达及其对心肌细胞凋亡和炎症因子分泌的影响[J]. 中国老年学杂志, 2022, 42(6): 1430-1435.
|
[26]
|
Li, B., Xia, Y. and Hu, B. (2020) Infection and Atherosclerosis: TLR-Dependent Pathways. Cellular and Molecular Life Sciences, 77, 2751-2769. https://doi.org/10.1007/s00018-020-03453-7
|
[27]
|
Zou, Y., Huang, Y., Liu, S., et al. (2022) Periodontopathic Microbiota and Atherosclerosis: Roles of TLR-Mediated Inflammation Response. Oxidative Medicine and Cellular Longevity, 2022, Article ID: 9611362. https://doi.org/10.1155/2022/9611362
|
[28]
|
Grebe, A., Hoss, F. and Latz, E. (2018) NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis. Circulation Research, 122, 1722-1740. https://doi.org/10.1161/CIRCRESAHA.118.311362
|
[29]
|
Ridker, P.M., Everett, B.M., Thuren, T., et al. (2017) Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. New England Journal of Medicine, 377, 1119-1131. https://doi.org/10.1056/NEJMoa1707914
|
[30]
|
杨超茅, 杨志新, 马晓玲. AGEs-RAGE信号通路在糖尿病肾病中的作用机制及中医药研究进展[J]. 中医学报, 2019, 34(9): 1864-1868.
|
[31]
|
Wasim, R., Mahmood, T., Siddiqui, M.H., et al. (2022) Aftermath of AGE-RAGE Cascade in the Pathophysiology of Cardiovascular Ailments. Life Sciences, 307, Article ID: 120860. https://doi.org/10.1016/j.lfs.2022.120860
|
[32]
|
Dongliang, Y., Yang, R., Peng, S., et al. (2022) Guanxin Xiaoban Capsules Could Treat Atherosclerosis by Affecting the Gut Microbiome and Inhibiting the AGE–RAGE Signalling Pathway. Journal of Medical Microbiology, 71, Article ID: 001530. https://doi.org/10.1099/jmm.0.001530
|
[33]
|
Udalova, I., Monaco, C., Nanchahal, J., et al. (2017) Anti-TNF Therapy. In: Gordon, S., Ed., Myeloid Cells in Health and Disease: A Synthesis, Wiley. New York, 637-648. https://doi.org/10.1128/9781555819194.ch35
|
[34]
|
苏绍红, 张琳, 张俊峰. 白芍总苷对动脉粥样硬化大鼠TNF-α/P38MAPK/NF-κB/RBP4信号通路及其血清IL-17, IL-27, IL-33影响的研究[J]. 新中医, 2019, 51(7): 18-21.
|